CD8A and granulomatosis with polyangiitis: Importantly, rituximab reduced cytokine and chemokine production of CD8+ T cells and coculturing of B cells from untreated active GPA patients with CD8+ T cells from the same patients enhanced CD8+ T cell proinflammatory cytokine production, suggesting a pathogenic crosstalk between these cells [102].